Drug target, class level, and PathFX pathway information share utility for machine learning prediction of common drug-induced side effects
Introduction: Development of drugs often fails due to toxicity and intolerable side effects. Recent advancements in the scientific community have rendered it possible to leverage machine learning techniques to predict individual side effects with domain knowledge features (i.e., drug classification)...
Saved in:
| Main Authors: | Han Jie Liu, Jennifer L. Wilson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-11-01
|
| Series: | Frontiers in Drug Safety and Regulation |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fdsfr.2023.1287535/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leveraging AI to explore structural contexts of post-translational modifications in drug binding
by: Kirill E. Medvedev, et al.
Published: (2025-05-01) -
In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing
by: Rukhsar Afreen, et al.
Published: (2022-04-01) -
Investigation of the relationship between chronic hepatitis B and tuberculosis using bioinformatics and systems biology approaches
by: Jinyi He, et al.
Published: (2025-06-01) -
Editorial: Machine learning in computer-aided drug design
by: Ognjen Perišić, et al.
Published: (2025-02-01) -
Common adverse cutaneous drug reaction patterns and the causative drugs in Malaysia
by: N. H. Talib, et al.
Published: (2015-07-01)